Related Experiment Video
Updated: Jun 3, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
A multicenter survey of heparin prophylaxis practice in pediatric critical care
Margaret Clarke1, Eduardo da Cruz2, Julianne Koehler2
1Department of Pediatrics, Section of Critical Care, The Children's Hospital of Aurora, University of Colorado School of Medicine, Aurora, CO, USA.
Abstract:
Heparin prophylaxis (HP) is commonly used for prevention of central venous catheter (CVC)-related complications among pediatric intensivists, yet efficacy of this therapy is unknown. We conducted a survey of pediatric intensivists and their experiences with HP. A total of 96 responses were received. Almost half of the respondents regularly used HP in patients with CVCs, yet most were unsure of its benefit. The majority of respondents claimed to experience no adverse effects; the complications that were reported to occur were related to bleeding or suspected heparin-induced thrombocytopenia (HIT). Overall, participants felt CVC-associated HP was safe in pediatric critical illness, while acknowledging the paucity of compelling data.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pharmacokinetics in Pediatric Patients: Drug Distribution
Venous Thrombosis III: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

